| Decitabine | Approved Investigational | GOT1L1 | 137362 |
upregulated | decitabine results in increased expression of GOT1L1 mRNA | 8p11.23 | |
| Decitabine | Approved Investigational | GPR162 | 27239 |
downregulated | decitabine results in decreased expression of GPR162 mRNA | 12p13 | |
| Decitabine | Approved Investigational | GPX3 | 2878 |
upregulated | decitabine results in increased expression of GPX3 mRNA | 5q33.1 | |
| Decitabine | Approved Investigational | GREM1 | 26585 |
upregulated | decitabine results in increased expression of GREM1 mRNA | 15q13.3 | |
| Decitabine | Approved Investigational | GSTM2 | 2946 |
upregulated | decitabine results in increased expression of GSTM2 mRNA | 1p13.3 | |
| Decitabine | Approved Investigational | GSTO1 | 9446 |
upregulated | decitabine results in increased expression of GSTO1 mRNA | 10q25.1 | |
| Decitabine | Approved Investigational | GSTP1 | 2950 |
upregulated | decitabine results in increased expression of GSTP1 mRNA | 11q13.2 | |
| Decitabine | Approved Investigational | GTPBP1 | 9567 |
upregulated | decitabine results in increased expression of GTPBP1 mRNA | 22q13.1 | |
| Decitabine | Approved Investigational | GTPBP2 | 54676 |
upregulated | decitabine results in increased expression of GTPBP2 mRNA | 6p21.1 | |
| Decitabine | Approved Investigational | GYPC | 2995 |
downregulated | decitabine results in decreased expression of GYPC mRNA | 2q14.3 | |
| Decitabine | Approved Investigational | HDAC2 | 3066 |
downregulated | decitabine results in decreased expression of HDAC2 mRNA | 6q21 | |
| Decitabine | Approved Investigational | HELB | 92797 |
upregulated | decitabine results in increased expression of HELB mRNA | 12q14.3 | |
| Decitabine | Approved Investigational | HIC1 | 3090 |
upregulated | decitabine results in increased expression of HIC1 mRNA | 17p13.3 | |
| Decitabine | Approved Investigational | HIST2H2AA3 | 8337 |
upregulated | decitabine results in increased expression of HIST2H2AA3 mRNA | 1q21.2 | |
| Decitabine | Approved Investigational | HLA-G | 3135 |
upregulated | decitabine results in increased expression of HLA-G mRNA | 6p22.1 | |
| Decitabine | Approved Investigational | HMGB1 | 3146 |
downregulated | decitabine results in decreased expression of HMGB1 mRNA | 13q12.3 | |
| Decitabine | Approved Investigational | HMGCS1 | 3157 |
downregulated | decitabine results in decreased expression of HMGCS1 mRNA | 5p12 | |
| Decitabine | Approved Investigational | HNRNPF | 3185 |
upregulated | decitabine results in increased expression of HNRNPF mRNA | 10q11.21 | |
| Decitabine | Approved Investigational | HOXA9 | 3205 |
upregulated | decitabine results in increased expression of HOXA9 mRNA | 7p15.2 | |
| Decitabine | Approved Investigational | HOXD3 | 3232 |
upregulated | decitabine results in increased expression of HOXD3 mRNA | 2q31.1 | |
| Decitabine | Approved Investigational | HRAS | 3265 |
downregulated | decitabine results in decreased expression of HRAS mRNA | 11p15.5 | |
| Decitabine | Approved Investigational | HSD11B2 | 3291 |
upregulated | decitabine results in increased expression of HSD11B2 mRNA | 16q22.1 | |
| Decitabine | Approved Investigational | HSDL2 | 84263 |
downregulated | decitabine results in decreased expression of HSDL2 mRNA | 9q32 | |
| Decitabine | Approved Investigational | HSPA6 | 3310 |
upregulated | decitabine results in increased expression of HSPA6 mRNA | 1q23.3 | |
| Decitabine | Approved Investigational | HSPA8 | 3312 |
upregulated | decitabine results in increased expression of HSPA8 mRNA | 11q24.1 | |